Bank of Montreal
SLNO

Bank of Montreal’s Soleno Therapeutics SLNO Stock Holding History

Bank of Montreal’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-176
Closed -$3K – 4775
2021
Q1 		$3K Sell
176
-501
-74% -$16.1K ﹤0.01% 4842
2020
Q4 		$23K Buy
677
+437
+182% +$12.6K ﹤0.01% 4361
2020
Q3 		$7K Buy
240
+7
+3% +$205 ﹤0.01% 4297
2020
Q2 		$7K Buy
+233
New +$10.1K ﹤0.01% 4341

Other funds holding SLNO

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Bank of Montreal's SLNO Position: Q2 2021 in Review

Bank of Montreal sold out of Soleno Therapeutics (SLNO) in Q2 2021, closing a stake of 176 shares — an estimated $3K sold.

Bank of Montreal first reported a position in SLNO in Q2 2020 and held it in 4 quarters. The position peaked at $23K in Q4 2020. 47 funds tracked by Wall St. Rank hold SLNO as of Q2 2021.

  • Bank of Montreal reported no remaining Soleno Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 176 Soleno Therapeutics shares in Q2 2021, an estimated $3K.
  • Bank of Montreal first reported a position in Soleno Therapeutics in Q2 2020 and held it in 4 quarters.
  • Bank of Montreal's Soleno Therapeutics position peaked at $23K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.